Month: December 2022

December 7, 2022

We have used Eculizumab in past at multiple instances and published our experience

There’s a need to have more anti-complement drugs in Indian market. Eculizumab is costly and difficult to procure, at times when it’s needed. We have used Eculizumab in past at multiple instances and published our experience. From next year, our center would be part of multinational, multicentric trial for a new subcutaneous C5 blocker Crovalimab

Read More